Entero Therapeutics, Inc. (ENTO) Dividend History

Entero Therapeutics, Inc. (ENTO) is a biopharmaceutical company focused on developing neuromodulation therapies for gastrointestinal and metabolic diseases. The company leverages its proprietary EnteroMedics platform, including the vagus nerve modulation technology, to develop treatments aimed at improving conditions such as obesity and other gastrointestinal disorders.